Portable Duplex Diagnostic Platform for Point-of-Care Differentiation of Ebola and Lassa Virus
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c00820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Wenting Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Meinig School of Biomedical Engineering, Cornell University, 121 Weill Hall, 237 Tower Road, Ithaca, New York14853, United States. Hauptthemen laut MEDLINE: Lassa virus, Ebolavirus, Point-of-Care Systems, Lassa Fever. Die Arbeit nennt 81 Literaturangaben. Gefördert von: Military Infectious Diseases Research Program, National Institutes of Health (NIH).
Abstract (Originalsprache)
Ebola virus (EBOV) and Lassa virus (LASV) infections present with indistinguishable early symptoms, creating a persistent diagnostic gap in coendemic regions. This challenge is compounded in resource-limited settings, where existing lateral flow assays are single-target, qualitative, and reliant on subjective interpretation. We developed a duplex colorimetric lateral flow immunoassay (LFIA) for simultaneous detection of EBOV VP40 and LASV nucleoprotein (NP), integrated with the Portable Rapid Onsite Versatile Image-based Detection System (PROVIDS), a compact optical reader that automates line segmentation, trichannel deconvolution, and test-to-control ratio quantification in under 5 s. The assay achieved limits of detection of 44 ng/mL for EBOV and 69 ng/mL for LASV, with intra-assay CVs below 10%, retained full analytical performance after 8 weeks of ambient storage, and showed high specificity for Zaire-lineage EBOV and LASV lineages II (Macenta) and IV (Josiah) without cross-reactivity to Marburg virus (MARV). Meeting WHO Target Product Profile (TPP) benchmarks, this PROVIDS-enabled duplex LFIA provides a portable, quantitative, and multiplexed platform for outbreak triage and establishes a scalable foundation for future syndromic surveillance of viral hemorrhagic fevers (VHFs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Meinig School of Biomedical Engineering, Cornell University, 121 Weill Hall, 237 Tower Road, Ithaca, New York14853, United States.
- U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) , 1425 Porter Street, Fort Detrick, Frederick, Maryland21702-5011, United States.
- Sibley School of Mechanical and Aerospace Engineering, Cornell University, Upson Hall, 124 Hoy Road, Ithaca, New York14853, United States.
- College of Arts and Sciences, Cornell University, Klarman Hall, 232 Feeney Way, Ithaca, New York14853, United States.
- Cornell Joan Klein Jacobs Center for Precision Nutrition and Health, College of Human Ecology, Cornell University3219 Martha Van Rensselaer Hall, 116 Reservoir Avenue, Ithaca, New York14853, United States.
- Center for Point-Of-Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT), Cornell University, 369 Upson Hall, 124 Hoy Road, Ithaca, New York14850, United States.
ORCID-Profile: Wenting Gao, Saurabh Mehta, David Erickson
Förderung
- Military Infectious Diseases Research Program
- National Institutes of Health (NIH)
Zitieren
APA
Gao, W., Nikolaou, T. A., Almeida, M., Consul, A., Guo, Y., Olguin, V., Un, C., Elbedawi, N., Ganguly, A., Diop, M., Mehta, S., Ricks, K., & Erickson, D. (2026). Portable Duplex Diagnostic Platform for Point-of-Care Differentiation of Ebola and Lassa Virus. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c00820
Vancouver
Gao W, Nikolaou TA, Almeida M, Consul A, Guo Y, Olguin V, et al. Portable Duplex Diagnostic Platform for Point-of-Care Differentiation of Ebola and Lassa Virus. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c00820
BibTeX
@article{Gao2026,
author = {Gao, Wenting and Nikolaou, Theopisti A and Almeida, Monalisa and Consul, Amber and Guo, Yunting and Olguin, Victoria and Un, Clarence and Elbedawi, Noon and Ganguly, Antra and Diop, Maguette and Mehta, Saurabh and Ricks, Keersten and Erickson, David},
title = {Portable Duplex Diagnostic Platform for Point-of-Care Differentiation of Ebola and Lassa Virus},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c00820}
}
EUVIMED